RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 RIS with Dissemination on MRI
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 2
SP 9
OP 9
DO 10.1177/155989771202006
UL http://mdc.sagepub.com/content/12/2/9.1.abstract
AB Although disease-modifying therapies work best when given early in MS, the decision to proactively treat patients with radiologically isolated syndrome (RIS) is countered by the increasing risks associated with disease-modifying therapies as well as the uncertain prognostic outcome of RIS [Spain R, Bourdette D. Curr Neurol Neurosci Rep 2011].